Morgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias, the company's promoters, own the remaining 45%.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/13F4CcZ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMT
0 comments:
Post a Comment